Selon les derniers rapports financiers de Glenmark Pharmaceuticals , la dette totale de l'entreprise est de 0.19 Milliard d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.
Année | Dette totale | Changement |
---|---|---|
2024-03-31 | €0.13 Md | -73.44% |
2023-03-31 | €0.51 Md | 9.95% |
2022-03-31 | €0.46 Md | -19.16% |
2021-03-31 | €0.57 Md | -7.14% |
2020-03-31 | €0.62 Md | 9.32% |
2019-03-31 | €0.57 Md | -1.28% |
2018-03-31 | €0.57 Md | -15.3% |
2017-03-31 | €0.68 Md | 28.68% |
2016-03-31 | €0.53 Md | -5.55% |
2015-03-31 | €0.56 Md | 41.39% |
2014-03-31 | €0.39 Md | -0.05% |
2013-03-31 | €0.39 Md | 20.04% |
2012-03-31 | €0.33 Md | -1.13% |
2011-03-31 | €0.33 Md | 8.35% |
2010-03-31 | €0.30 Md | -0.77% |
2009-03-31 | €0.31 Md | 97.47% |
2008-03-31 | €0.15 Md | -3.07% |
2007-03-31 | €0.16 Md | 19.31% |
2006-03-31 | €0.13 Md | 76.21% |
2005-03-31 | €77.36 M | 259.34% |
2004-03-31 | €21.52 M |